ID   Hermes-3
AC   CVCL_4525
SY   HERMES 3
DR   CLO; CLO_0003715
DR   Wikidata; Q54882893
RX   Patent=US5403919;
RX   PubMed=2442176;
RX   PubMed=2646376;
WW   http://web.stanford.edu/group/butlab//anti_atcc.htm
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9480.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
RX   Patent=US5403919;
RA   Butcher E.C.;
RT   "Method to control leukocyte extravasation.";
RL   Patent number US5403919, 04-Apr-1995.
//
RX   PubMed=2442176; DOI=10.1083/jcb.105.2.983;
RA   Jalkanen S.T., Bargatze R.F., de los Toyos J., Butcher E.C.;
RT   "Lymphocyte recognition of high endothelium: antibodies to distinct
RT   epitopes of an 85-95-kD glycoprotein antigen differentially inhibit
RT   lymphocyte binding to lymph node, mucosal, or synovial endothelial
RT   cells.";
RL   J. Cell Biol. 105:983-990(1987).
//
RX   PubMed=2646376; DOI=10.4049/jimmunol.142.6.2046;
RA   Picker L.J., de los Toyos J., Telen M.J., Haynes B.F., Butcher E.C.;
RT   "Monoclonal antibodies against the CD44 [In(Lu)-related p80], and
RT   Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing
RT   receptors.";
RL   J. Immunol. 142:2046-2051(1989).
//